Cargando…

Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy

The most prevalent primary glomerulonephritis and leading cause of end-stage renal disease worldwide is IgA nephropathy (IgAN). More and more studies are describing urinary microRNA (miRNA) as a non-invasive marker for a variety of renal diseases. We screened candidate miRNAs based on data from thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Meng, Duan, Zhi-Yu, Zhang, Qiu-Yue, Xu, Xie-Guan-Xuan, Zhang, Yan, Wang, Peng, Duan, Shu-Wei, Wu, Jie, Chen, Xiang-Mei, Cai, Guang-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101996/ https://www.ncbi.nlm.nih.gov/pubmed/37055445 http://dx.doi.org/10.1038/s41598-023-32910-z

Ejemplares similares

The Utility of Assessing CD68+ Glomerular Macrophages in Assessing Endocapillary Hypercellularity in IgA Nephropathy
por: Agrawal, Neha, et al.
Publicado: (2021)

The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy
por: Hodgin, Jeffrey B., et al.
Publicado: (2014)

Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus Nephritis
por: Bos, Elisabeth M.J., et al.
Publicado: (2022)

Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients
por: Kaihan, Ahmad Baseer, et al.
Publicado: (2019)

Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
por: Hirano, Keita, et al.
Publicado: (2015)

Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE
por: Li, Chunzhen, et al.
Publicado: (2022)

Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy
por: Li, Yan, et al.
Publicado: (2021)

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)

U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2018)

Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy
por: Liang, Shuang, et al.
Publicado: (2017)

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015)

Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease
por: Hu, Xueli, et al.
Publicado: (2022)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy
por: Yang, Joshua Y. C., et al.
Publicado: (2019)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Urinary miRNA profile for the diagnosis of IgA nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2019)

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Association between urinary VEGFA and renal pathology of IgA nephropathy patients
por: Feng, Shaozhen, et al.
Publicado: (2021)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
por: Sun, Qiang, et al.
Publicado: (2016)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

MicroRNAs in IgA nephropathy
por: Yao, Xingchen, et al.
Publicado: (2021)

IgA Nephropathy: A Chinese Perspective
por: Zhang, Zhao, et al.
Publicado: (2021)

Iron metabolism and chronic inflammation in IgA nephropathy
por: Tian, Zhang-yu, et al.
Publicado: (2023)

Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2010)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy
por: Guan, Jie, et al.
Publicado: (2023)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g0m9so05jive5uloja36t0qboi